# Shandong Ruiying Pioneer Pharmaceutical Co., Ltd – FDA Inspection, Mar 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/shandong-ruiying-pioneer-pharmaceutical-co-ltd/1cac6f1a-546d-4bc3-85ba-71da7351dbb6
Source feed: FDA_Inspections

> FDA inspection 1264014 of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd, March 07, 2025. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264014
- Company Name: Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- Inspection Date: 2025-03-07
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1086433 - 2019-03-22](https://www.keypedia.com/records/fda_inspections/shandong-ruiying-pioneer-pharmaceutical-co-ltd/25050831-a9e8-4a77-aa7c-4521a632078f)
- FDA Inspection 920919 - 2015-03-27
- FDA Inspection 707439 - 2010-09-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)

Company: https://www.keypedia.com/companies/shandong-ruiying-pioneer-pharmaceutical-co-ltd/574c4f09-5a4e-4428-b84d-cb139c05ff9b

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
